These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 21927559)
1. Radiofrequency ablation for treating liver metastases from a non-colorectal origin. Yun BL; Lee JM; Baek JH; Kim SH; Lee JY; Han JK; Choi BI Korean J Radiol; 2011; 12(5):579-87. PubMed ID: 21927559 [TBL] [Abstract][Full Text] [Related]
2. Salvage RFA in patients with intrahepatic recurrence after major hepatic surgery for colorectal cancer liver metastases: mid-term outcome. Zimmermann M; Pedersoli F; Schulze-Hagen M; Lurje G; Isfort P; Kuhl C; Bruners P Eur Radiol; 2020 Feb; 30(2):1221-1227. PubMed ID: 31493210 [TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease. Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366 [TBL] [Abstract][Full Text] [Related]
5. CT versus MR guidance for radiofrequency ablation in patients with colorectal liver metastases: a 10-year follow-up favors MR guidance. Pereira PL; Siemou P; Rempp HJ; Hoffmann R; Hoffmann RT; Kettenbach J; Clasen S; Helmberger T Eur Radiol; 2024 Jul; 34(7):4663-4671. PubMed ID: 38041717 [TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency ablation with multiple electrodes for medium-sized hepatocellular carcinomas. Lee J; Lee JM; Yoon JH; Lee JY; Kim SH; Lee JE; Han JK; Choi BI Korean J Radiol; 2012; 13(1):34-43. PubMed ID: 22247634 [TBL] [Abstract][Full Text] [Related]
7. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach. Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075 [TBL] [Abstract][Full Text] [Related]
8. Hepatic radiofrequency under CT-fluoroscopy guidance. Laganà D; Carrafiello G; Mangini M; Lumia D; Mocciardini L; Chini C; Pinotti G; Cuffari S; Fugazzola C Radiol Med; 2008 Feb; 113(1):87-100. PubMed ID: 18338130 [TBL] [Abstract][Full Text] [Related]
10. Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases. White TJ; Roy-Choudhury SH; Breen DJ; Cast J; Maraveyas A; Smyth EF; Hartley JE; Monson JR Dig Surg; 2004; 21(4):314-20. PubMed ID: 15365230 [TBL] [Abstract][Full Text] [Related]
11. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175 [TBL] [Abstract][Full Text] [Related]
12. Bipolar radiofrequency ablation of liver metastases during laparotomy. First clinical experiences with a new multipolar ablation concept. Ritz JP; Lehmann KS; Reissfelder C; Albrecht T; Frericks B; Zurbuchen U; Buhr HJ Int J Colorectal Dis; 2006 Jan; 21(1):25-32. PubMed ID: 15875202 [TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation for the treatment of primary intrahepatic cholangiocarcinoma. Kim JH; Won HJ; Shin YM; Kim KA; Kim PN AJR Am J Roentgenol; 2011 Feb; 196(2):W205-9. PubMed ID: 21257864 [TBL] [Abstract][Full Text] [Related]
15. Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablation. Ierardi AM; Floridi C; Fontana F; Chini C; Giorlando F; Piacentino F; Brunese L; Pinotti G; Bacuzzi A; Carrafiello G Radiol Med; 2013 Sep; 118(6):949-61. PubMed ID: 23892957 [TBL] [Abstract][Full Text] [Related]
16. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma]. Wu J; Chen MH; Yang W; Wu W; Yan K Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates. Meloni MF; Andreano A; Laeseke PF; Livraghi T; Sironi S; Lee FT Radiology; 2009 Dec; 253(3):861-9. PubMed ID: 19709994 [TBL] [Abstract][Full Text] [Related]
18. Radiomics complements clinical, radiological, and technical features to assess local control of colorectal cancer lung metastases treated with radiofrequency ablation. Markich R; Palussière J; Catena V; Cazayus M; Fonck M; Bechade D; Buy X; Crombé A Eur Radiol; 2021 Nov; 31(11):8302-8314. PubMed ID: 33954806 [TBL] [Abstract][Full Text] [Related]
19. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe]. Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704 [TBL] [Abstract][Full Text] [Related]
20. Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma. Lee SJ; Kim JH; Kim SY; Won HJ; Shin YM; Kim PN Korean J Radiol; 2020 Mar; 21(3):316-324. PubMed ID: 32090524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]